BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37525872)

  • 21. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
    Zhang JZ; Yang CX; Gao S; Bu JF; Li QQ; Wang HL; Yang KN; Tong SS; Qian LJ; Zhang J; Hua R; Sun YW; Yan JY; Chen W
    World J Surg Oncol; 2023 Aug; 21(1):239. PubMed ID: 37542314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive treatment of advanced hilar cholangiocarcinoma: A case report.
    Li L; Zeng J; Tao L; Song J
    Asian J Surg; 2023 Nov; 46(11):5393-5394. PubMed ID: 37541878
    [No Abstract]   [Full Text] [Related]  

  • 23. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
    Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
    Li H; Su K; Guo L; Jiang Y; Xu K; Gu T; Chen J; Wu Z; Wang P; Zhang X; Yan Y; Li S; Wu X; Han L; He K; Wen L; Li B; Han Y
    J Hepatocell Carcinoma; 2023; 10():1257-1266. PubMed ID: 37538403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.
    Dai Y; Zhang X; Ou Y; Zou L; Zhang D; Yang Q; Qin Y; Du X; Li W; Yuan Z; Xiao Z; Wen Q
    Cell Commun Signal; 2023 Aug; 21(1):190. PubMed ID: 37537585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orthodeoxia Platypnea Syndrome in the Setting of Cholangiocarcinoma: A Case Report.
    Kamel M; Malik A; Sarkar K; Narine B; Garcia-Bengochea Y; Makaryus JN; Singh A
    Am J Cardiol; 2023 Oct; 204():64-69. PubMed ID: 37536206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: Research trends of targeted therapy for cholangiocarcinoma from 2003 to 2022: a bibliometric and visual analysis.
    Huang P; Wen F; Wu Q; Zhang P; Li Q
    Clin Exp Med; 2023 Dec; 23(8):5477. PubMed ID: 37535196
    [No Abstract]   [Full Text] [Related]  

  • 28. Case Report. Diagnostic Challenges: Liver Metastases from Mammary Gland Origin or Cholangiocarcinoma?
    Tocu G; Popa IT; Ivan I; Anghel L; Nechita LA; Musat CL; Rebegea LF; Tutunaru D
    Int J Womens Health; 2023; 15():1205-1211. PubMed ID: 37534051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unconventional treatment of inoperable biliary IPMN with an oesophageal stent in the common bile duct: case report.
    Siiki A; Antila A; Vaalavuo Y; Ronkainen J; Rinta-Kiikka I; Laukkarinen J
    Ther Adv Gastrointest Endosc; 2023; 16():26317745231183311. PubMed ID: 37533690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of neutrophil-related genes and development of a prognostic model for cholangiocarcinoma.
    Li J; Xiong J; Wei L; Zhang M; Yi J; Liu L
    J Gene Med; 2024 Jan; 26(1):e3569. PubMed ID: 37533324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma.
    Olthof PB; Franssen S; van Keulen AM; van der Geest LG; Hoogwater FJH; Coenraad M; van Driel LMJW; Erdmann JI; Mohammad NH; Heij L; Klümpen HJ; Tjwa E; Valkenburg-van Iersel L; Verheij J; Groot Koerkamp B;
    HPB (Oxford); 2023 Nov; 25(11):1329-1336. PubMed ID: 37532665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
    Okano N; Morizane C; Okusaka T; Sadachi R; Kataoka T; Kobayashi S; Ikeda M; Ozaka M; Mizutani T; Sugimori K; Todaka A; Shimizu S; Mizuno N; Yamamoto T; Sano K; Tobimatsu K; Katanuma A; Gotoh K; Yamaguchi H; Ishii H; Ohba A; Furuse J; Ueno M;
    Oncologist; 2024 Jan; 29(1):e97-e107. PubMed ID: 37531645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study.
    Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K
    BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.
    Adekolujo OS; Wahab A; Akanbi MO; Oyasiji T; Hrinczenko B; Alese OB
    Cancer Biol Ther; 2023 Dec; 24(1):2198479. PubMed ID: 37526431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatologic manifestations of acute graft versus host disease after liver transplantation: A case series of 8 patients.
    Kaur M; Singh N; Mital R; Schenk A; Fisher K; Korman AM; Kaffenberger BH; Chung CG
    JAAD Case Rep; 2023 Sep; 39():6-13. PubMed ID: 37554362
    [No Abstract]   [Full Text] [Related]  

  • 36. Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host disease.
    El Jurdi N; Holtan SG; Hoeschen A; Velguth J; Hillmann B; Betts BC; MacMillan ML; Weisdorf DJ; Khoruts A; Rashidi A; Shields-Cutler R
    Br J Haematol; 2023 Oct; 203(2):288-294. PubMed ID: 37553783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy.
    Fuji S; Hakoda A; Kanda J; Fukuda T; Doki N; Katayama Y; Uchida N; Ozawa Y; Kanda Y; Tanaka M; Kataoka K; Ara T; Sawa M; Onizuka M; Onishi Y; Kimura T; Ichinohe T; Atsuta Y; Shintani A; Morishima S
    Bone Marrow Transplant; 2023 Nov; 58(11):1257-1259. PubMed ID: 37550450
    [No Abstract]   [Full Text] [Related]  

  • 38. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting FOXO1.
    Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
    Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications.
    Begolli G; Marković I; Knežević J; Debeljak Ž
    Biochem Med (Zagreb); 2023 Oct; 33(3):030503. PubMed ID: 37545696
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.